TABLE 2.
In-house modified WNV-specific IgM ELISA | No. of samples with final interpretation based on additional CDC/SPHL testing
|
||||
---|---|---|---|---|---|
Index | n | No additional reactivity identified | Dengue virus infection | SLE virus infection | WNV infection |
<1.00 | 3 | 3 | |||
1.00-2.00 | 8 | 3 | 2 | 1 | 2 |
2.01-3.00 | 9 | 2 | 2 | 5 | |
>3.00 | 34 | 3 | 31 | ||
Total | 54 | 11 | 4 | 1 | 38 |